| Literature DB >> 32698811 |
Jennifer Erley1, Radu Tanacli1, Davide Genovese2, Natalie Tapaskar3, Nina Rashedi3, Paulius Bucius1, Keigo Kawaji3,4, Ilya Karagodin3, Roberto M Lang3, Sebastian Kelle1,5,6, Victor Mor-Avi7, Amit R Patel3.
Abstract
BACKGROUND: Right ventricular (RV) strain is a useful predictor of prognosis in various cardiovascular diseases, including those traditionally believed to impact only the left ventricle. We aimed to determine inter-modality and inter-technique agreement in RV longitudinal strain (LS) measurements between currently available cardiovascular magnetic resonance (CMR) and echocardiographic techniques, as well as their reproducibility and the impact of layer-specific strain measurements.Entities:
Keywords: Cardiovascular magnetic resonance; Right-ventricular function; Speckle-tracking echocardiography
Mesh:
Year: 2020 PMID: 32698811 PMCID: PMC7376701 DOI: 10.1186/s12968-020-00647-7
Source DB: PubMed Journal: J Cardiovasc Magn Reson ISSN: 1097-6647 Impact factor: 5.364
Fig. 1Representative speckle tracking echocardiography (STE)-image, strain curves and end-systolic strain values of a patient with pulmonary artery hypertension and right-sided heart failure (LVEF:56%, RVEF:28%). LVEF, left ventricular ejection fraction; RVEF, right ventricular ejection fraction. GLS = global longitudinal strain, FWLS = free wall longitudinal strain
Fig. 2Representative feature tracking (FT)-images, demonstrating the two contouring approaches to determine subendocardial (Endo-FT) and midmyocardial (Myo-FT) strain, as well as the corresponding strain curves and end-systolic strain values for the same patient with pulmonary artery hypertension and right-sided heart failure
Fig. 3Representative strain encoding (SENC)-image, strain curve and end-systolic strain value of the same patient with pulmonary artery hypertension and right-sided heart failure. The color-coded images represent the myocardial contraction. GLS, global longitudinal strain
Demographic characteristics, diseases and median right ventricular strain values of the patients and volunteers
| Patients ( | Healthy subjects ( | |
|---|---|---|
| Age (years) | 56 (±19) | 24 (±5) |
| Female, n (%) | 33 (57.9%) | 9 (53%) |
LV-dysfunction (LVEF< 50%, e.g. HFrEF, CAD, arrhythmia), n (%) | 17 (29.8%) | / |
Preserved LVEF (LVEF> 50%, e.g. HFpEF, CAD, arrhythmia), n (%) | 13 (22.8%) | / |
| Pulmonary hypertension, RV-dysfunction, n (%) | 12 (21%) | / |
| Congenital heart disease, n (%) | 8 (14%) | / |
| Systemic rheumatic/ inflammatory disease, n (%) | 5 (8.8%) | / |
| Symptoms but no diagnosis on cardiac imaging, n (%) | 2 (3.5%) | / |
| Median (IQR) BSA (m2) | 1.9 (1.7–2.0) | 1.8 (1.7–1.9) |
| LVEF (from CMR) (%) | 51.2 (16.1) | 58.6 (5.1) |
| RVEF (from CMR) (%) | 51.8 (14.5) | 53.4 (5.8) |
| LVEF < 50% | 24 (42.1%) | 0 |
| RVEF< 50% | 18 (31.6%) | 2 (11.8%) |
| Median (IQR) GLS for STE | −16.0 (−20.0 to −14.0) | / |
| Median (IQR) FWLS for STE | −21.0 (−26.0 to −17.0) | / |
| Median (IQR) LS for Endo-FT | −25.2 (−32.5 to −21.6) | −27.6 (− 31.7 to −23.2) |
| Median (IQR) LS for Myo-FT | −26.3 (− 30.6 to − 20.6) | −25.6 (− 29.3 to − 22.4) |
| Median (IQR) LS for SENC | −18.0 (− 20.0 to − 15.8) | −18.6 (− 21.0 to − 17.7) |
Abbreviations: BSA Body surface area, LVEF Left ventricular ejection fraction, RVEF Right ventricular ejection fraction, IQR Interquartile range, GLS Global longitudinal strain, FWLS Free wall longitudinal strain, STE Speckle tracking echocardiography, SENC Strain-encoding, FT Feature tracking, Endo-FT Subendocardial strain determined using FT, Myo-FT Midmyocardial strain determined using FT, HFrEF Heart failure and reduced ejection fraction, HFpEF Heart failure and preserved ejection fraction
Inter-modality and inter-technique agreement for right ventricular strain measurements, shown by Bland-Altman analyses and correlation coefficients
| r | p | Bias (%) | LOA (%) | p | |
|---|---|---|---|---|---|
| SENC vs. STE | |||||
| SENC vs. STE-FWLS | 0.57 | < 0.001 | −3.6 | −12.2 to 5.0 | < 0.001 |
| SENC vs. STE-GLS | 0.63 | < 0.001 | 0.7 | −5.3 to 6.8 | 0.094 |
| FT vs. STE | |||||
| Endo-FT vs. STE -FWLS | 0.60 | < 0.001 | 6.8 | −9.8 to 23.5 | < 0.001 |
| Myo-FT vs. STE-FWLS | 0.62 | < 0.001 | 5.5 | −9.0 to 20.0 | < 0.001 |
| Endo-FT vs. STE-GLS | 0.50 | < 0.001 | 11.1 | −6.6 to 28.9 | < 0.001 |
| Myo-FT vs. STE-GLS | 0.54 | < 0.001 | 9.8 | −5.3 to 24.9 | < 0.001 |
| SENC vs. FT | |||||
| SENC vs. Endo-FT | 0.39 | 0.003 | −10.4 | −28.8 to 8.0 | < 0.001 |
| SENC vs. Myo-FT | 0.41 | 0.002 | −9.1 | −24.7 to 6.6 | < 0.001 |
| SENC vs. FT | |||||
| SENC vs. Endo-FT | 0.39 | 0.129 | −8.3 | −16.9 to 0.28 | < 0.001 |
| SENC vs. Myo-FT | 0.36 | 0.162 | −6.4 | −14.1 to 1.30 | < 0.001 |
Abbreviations: GLS Global longitudinal strain, FWLS Free wall longitudinal strain, STE Speckle tracking echocardiography, SENC strain-encoding, FT Feature tracking, Endo-FT Subendocardial strain determined using FT, Myo-FT Midmyocardial strain determined using FT, LOA Limits of agreement
Fig. 4Box-plot diagrams illustrating the distribution of strain values, determined using STE, FT and SENC in 57 patients. Ns, not significant; * = p < 0.05; *** = p < 0.001
Fig. 5Box-plot diagrams illustrating the distribution of strain values, determined using FT and SENC in the reference group of 17 healthy subjects. * = p < 0.05, *** = p < 0.001
Results of the Friedmann’s test to compare the different strain measurements in patients and healthy subjects, showing the adjusted significance level from the Dunn-Bonferoni post-hoc test (p) as well as the effect size (r) of the different comparisons
| p | r | |
|---|---|---|
| SENC vs. STE | ||
| SENC vs. STE-FWLS | 0.049 | 0.11 |
| SENC vs. STE-GLS | 1.000 | / |
| FT vs. STE | ||
| Endo-FT vs. STE -FWLS | < 0.001 | 0.18 |
| Myo-FT vs. STE-FWLS | 0.059 | / |
| Endo-FT vs. STE-GLS | < 0.001 | 0.36 |
| Myo-FT vs. STE-GLS | < 0.001 | 0.28 |
| SENC vs. FT | ||
| SENC vs. Endo-FT | < 0.001 | 0.29 |
| SENC vs. Myo-FT | < 0.001 | 0.22 |
| SENC vs. FT | ||
| SENC vs. Endo-FT | < 0.001 | 0.47 |
| SENC vs. Myo-FT | 0.006 | 0.26 |
Abbreviations: GLS Global longitudinal strain, FWLS Free wall longitudinal strain, STE Speckle tracking echocardiography, SENC Strain-encoding, FT Feature tracking, Endo-FT Subendocardial strain determined using FT, Myo-FT Midmyocardial strain determined using FT
Results of the reproducibility analysis, reported in terms of intraclass correlation coefficient (ICC) and Coefficient of Variation (CoV)
| ICC (95%CI) | p | CoV (±SD) | ||
|---|---|---|---|---|
| Intra-Observer Reproducibility | STE-FWLS | 0.94 (0.79–0.99) | < 0.001 | 0.07 (0.03) |
| STE-GLS | 0.93 (0.75–0.98) | < 0.001 | 0.08 (0.06) | |
| SENC | 0.91 (0.71–0.98) | < 0.001 | 0.04 (0.03) | |
| Sub-FT | 0.96 (0.85–0.99) | < 0.001 | 0.06 (0.05) | |
| Myo-FT | 0.88 (0.50–0.97) | 0.003 | 0.12 (0.10) | |
| Inter-Observer Reproducibility | STE-FWLS | 0.93 (0.75–0.98) | < 0.001 | 0.07 (0.03) |
| STE-GLS | 0.92 (0.72–0.98) | < 0.001 | 0.06 (0.06) | |
| SENC | 0.90 (0.66–0.98) | < 0.001 | 0.04 (0.02) | |
| Endo-FT | 0.62 (−0.22–0.91) | 0.002 | 0.29 (0.11) | |
| Myo-FT | 0.67 (−0.16–0.93) | < 0.001 | 0.30 (0.12) |
Abbreviations: GLS Global longitudinal strain, FWLS Free wall longitudinal strain, STE Speckle tracking echocardiography, SENC Strain-encoding, FT Feature tracking, Endo-FT Subendocardial strain determined using FT, Myo-FT Midmyocardial strain determined using FT, ICC Intraclass correlation coefficient, CI Confidence interval, CoV Coefficient of variation, SD Standard deviation